Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Research Opportunities November 2021

Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies

PDF

Leonard A. Levin; Mohor Sengupta; Laura J. Balcer; Mark J. Kupersmith; Neil R. Miller
TAGS: eye, optic nerve disorders, surrogate endpoints
Invest. Ophthalmol. Vis. Sci.. 2021; 62(14):30. doi: https://doi.org/10.1167/iovs.62.14.30

ARVO Annual Meeting Abstract April 2011

Relation of Ganglion Cell Layer Thinning to Axonal Loss, Visual Function, and Quality of Life in Multiple Sclerosis

Scott D. Walter; Hiroshi Ishikawa; Kristin Galetta; James Wilson; Steven Galetta; Elliot Frohman; Peter Calabresi; Joel S. Schuman; Laura J. Balcer

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6658. doi:

ARVO Annual Meeting Abstract April 2011

Comparison of Retinal Nerve Fiber Layer Thickness and Macular Thickness/Volume Among Patients with Relapsing-Remitting Multiple Sclerosis: Baseline Data from a Phase 3 Trial of Fingolimod

Kimberly M. Winges; Jack S. Werner; Danielle J. Harvey; Peter A. Calabresi; Laura J. Balcer; Kim E. Cello; Laurel A. Nelson; John L. Keltner

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5308. doi:

ARVO Annual Meeting Abstract April 2011

Macular Segmentation in Multiple Sclerosis (MS) Eyes With Optic Neuritis (ON) Episode Using Spectral Domain Optical Coherence Tomography (SD-OCT)

Chieh-Li Chen; Hiroshi Ishikawa; James Wilson; Richard A. Bilonick; Gadi Wollstein; Laura J. Balcer; Joel S. Schuman

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2997. doi:

Advertisement